MarketsStocksGLENMARK
GL

Glenmark Pharmaceuticals Ltd

NSE: GLENMARKBSE: 532296Healthcare
2,174.00
-0.49%
NSE · 15-min delayed
Prev Close
₹1,514.00
Day High
₹2,222.00
Day Low
₹2,148.20
Mkt Cap
₹64,198 Cr
P / E
47.1
P / B
6.1
ROE
13.0%
52W High
₹2,474.00
52W Low
₹1,380.00
Key Metrics
Market Cap
₹64,198 Cr
P / E
47.1
P / B
6.1
ROCE
20.9%
ROE
13.0%
Div Yield
0.2%
Revenue · ₹ Cr
11k
FY20
11k
FY21
12k
FY22
13k
FY23
12k
FY24
13k
FY25
17k
FY26
Net Profit · ₹ Cr
776
FY20
970
FY21
994
FY22
377
FY23
-1k
FY24
1k
FY25
1k
FY26
EPS · ₹ per share
₹27.5
FY20
₹34.4
FY21
₹33.4
FY22
₹10.5
FY23
₹-53.2
FY24
₹37.1
FY25
₹48.3
FY26
P / E Ratio · price ÷ TTM EPS
072145217173552Jun 21Jan 23Oct 24Jun 26
P/E 45.0×Median 52.9×TTM EPS
Q1 2026 snapshot
Sales
₹3.96K Cr
Operating profit
-
OPM
-
Net profit
₹301 Cr
EPS
₹10.68
Scorecard · 7 axes
Quality
Good
72/100
Valuation
Weak
47.1×
Growth
Avg
+8.6%
Profitability
Good
16.9%
Performance
Strong
+61.8%
Entry Point
Avg
88%
Red Flags
Strong
0 flags
Shareholding Pattern
46.6%Promoter
Promoter46.6%
FII20.3%
DII19.3%
Public13.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue3,387.5523,267.893,290.886,247.53,945.083,959.67
Net Profit348.0314.38446.973610.432403.228301.319
NPM %10.3%0.1%1.4%9.8%10.2%7.6%
AlertPre-trade